New research has found that a drug commonly used to treat a broad range of fungal infections, including skin and nail infections, has a lot of potential as a new cancer treatment. Itraconazole, a generic anti-fungal agent that costs relatively less, shows some evidence of efficacy in metastatic prostate cancer -- which would make it an attractive proposition given the high costs associated with cancer treatments such as arbiraterone, said Pan Pantziarka, member ...
Read More
You have just read an article categorized health
titled Common Anti-fungal Drug, Itraconazole, Shows Potential in Cancer Treatment.
Written by:
editor -
Thursday, April 16, 2015
There are currently no comments for "Common Anti-fungal Drug, Itraconazole, Shows Potential in Cancer Treatment"
Post a Comment